SARS-CoV-2 Infection Risk Factors in Beijing during November 2022: A Case Control Study

ZHANG Jiao Jiao SHEN Ying SUN Ying LI Jia MA Jia Xin ZHANG Dai Tao WANG Quan Yi YANG Peng

ZHANG Jiao Jiao, SHEN Ying, SUN Ying, LI Jia, MA Jia Xin, ZHANG Dai Tao, WANG Quan Yi, YANG Peng. SARS-CoV-2 Infection Risk Factors in Beijing during November 2022: A Case Control Study[J]. Biomedical and Environmental Sciences, 2023, 36(11): 1100-1104. doi: 10.3967/bes2023.141
Citation: ZHANG Jiao Jiao, SHEN Ying, SUN Ying, LI Jia, MA Jia Xin, ZHANG Dai Tao, WANG Quan Yi, YANG Peng. SARS-CoV-2 Infection Risk Factors in Beijing during November 2022: A Case Control Study[J]. Biomedical and Environmental Sciences, 2023, 36(11): 1100-1104. doi: 10.3967/bes2023.141

doi: 10.3967/bes2023.141

SARS-CoV-2 Infection Risk Factors in Beijing during November 2022: A Case Control Study

Funds: This research was supported by the Ministry of Science and Technology of the People's Republic of China.
More Information
    Author Bio:

    ZHANG Jiao Jiao, female, born in 1993, postgraduate, majoring in infectious disease epidemiology

    SHEN Ying, female, born in 1994, postgraduate, majoring in infectious disease epidemiology

    Corresponding author: ZHANG Dai Tao, Tel: 86-10-64407108, E-mail: zdt016@163.com
  • The authors declare no conflicts of interest in the present study.
  • &These authors contributed equally to this work.
图(2) / 表ll (1)
计量
  • 文章访问数:  135
  • HTML全文浏览量:  59
  • PDF下载量:  9
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-05-27
  • 录用日期:  2023-08-28
  • 刊出日期:  2023-11-20

SARS-CoV-2 Infection Risk Factors in Beijing during November 2022: A Case Control Study

doi: 10.3967/bes2023.141
    基金项目:  This research was supported by the Ministry of Science and Technology of the People's Republic of China.
    作者简介:

    ZHANG Jiao Jiao, female, born in 1993, postgraduate, majoring in infectious disease epidemiology

    SHEN Ying, female, born in 1994, postgraduate, majoring in infectious disease epidemiology

    通讯作者: ZHANG Dai Tao, Tel: 86-10-64407108, E-mail: zdt016@163.com
注释:
1) Conflict of Interest:

English Abstract

ZHANG Jiao Jiao, SHEN Ying, SUN Ying, LI Jia, MA Jia Xin, ZHANG Dai Tao, WANG Quan Yi, YANG Peng. SARS-CoV-2 Infection Risk Factors in Beijing during November 2022: A Case Control Study[J]. Biomedical and Environmental Sciences, 2023, 36(11): 1100-1104. doi: 10.3967/bes2023.141
Citation: ZHANG Jiao Jiao, SHEN Ying, SUN Ying, LI Jia, MA Jia Xin, ZHANG Dai Tao, WANG Quan Yi, YANG Peng. SARS-CoV-2 Infection Risk Factors in Beijing during November 2022: A Case Control Study[J]. Biomedical and Environmental Sciences, 2023, 36(11): 1100-1104. doi: 10.3967/bes2023.141
  • Since the outbreak of COVID-19, countries and regions worldwide have implemented multifaceted prevention and control measures, including vaccinations, antiviral drugs, mask wearing, and social distancing. However, omicron variants, with significantly increased endogenous and occult transmission, have significantly complicated epidemic prevention and control[1]. Thus, studying the key and difficult aspects that affect the effectiveness of prevention and control of omicron can provide a reference for the spread of other respiratory infectious diseases. SARS-CoV-2 infection is influenced by multiple factors such as viral transmission, ventilation, personal protective equipment (PPE), population density, and contact time[2]. In November 2022, a new wave of the COVID-19 pandemic occurred in Beijing, China. Gene sequencing analysis indicated that the majority of SARS-CoV-2 cases at this stage were omicron variants BA.7 and BA.5.2[3]. To better understand the characteristics of the population infected with the omicron variant, our study adopted a case-control design to analyze the factors that affect SARS-CoV-2 infection in Beijing.

    Our study used a 1:4 case-control design. Participants were community-identified cases (case group) reported in Beijing in November 2022 and healthy people (control group) in the same community. A total of 995 participants completed the questionnaires. Subsequently, 434 were selectedvia Propensity Score Matching (PSM). The sample size estimation and investigation processes are presented in Supplementary 1 (available in www.besjournal.com).

    The inclusion criteria in the case group were as follows: 1) positive nucleic acid of SARS-CoV-2; 2) community-identified cases, defined as cases diagnosed in the community, who could freely transmit the virus through social interactions before quarantine or medical treatment; 3) age ≥ 18 years old; 4) willing to participate in this study based on the principle of informed consent.

    The exclusion criteria in the case group were as follows: 1) close contacts of known confirmed cases, 2) re-infection cases, 3) patients with severe conditions who could not cooperate with the investigators, and 4) individuals judged by the researchers as unsuitable for the study. Flow chart of study participants as shown in Supplementary Figure S1 (available in www.besjournal.com).

    Figure S1.  Flow chart of study participants. Participants with or without history of SARS-CoV-2 infection Beijing during November 2022 were considered. The left side of the diagram represents the flowchart for the COVID-19 group (community-found cases). The community-found cases were defined as cases, who could freely transmit the virus through social interactions before quarantine or medical treatment. The right side shows the inclusion flowchart for the non-COVID-19 group and matched through PSM, who living in the same community as the infected person. *There was no significant difference in age and gender between those refused and agreed to participate (P > 0.05).

    The inclusion criteria for the control group were as follows: 1) living in the same community as the infected person; 2) no positive antigen or nucleic acid detected within seven days after the infected person in the community was detected; 3) same sex; and 4) age difference of less than five years.

    The exclusion criteria for the control group were as follows: 1) living with infected individuals, 2) living on the same floor or in the same building as the infected person, and 3) a previous infection.

    All information was obtained via questionnaire conducted through face-to-face and telephone interviews. The information collected in the questionnaire included: 1) demographic data, including age, gender, vaccination status, and chronic diseases (defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both, such as heart disease, cancer, and diabetes); 2) residential environment, including residential type, ventilation condition, and number of roommates; 3) personal hygiene, including daily mask type, and hand disinfection; 4) nucleic acid sampling, including sampling frequency, type and position of sampling sites, ventilation conditions, arrangements of sampling site, mask type when sampling, and standardization of operation; 5) social activity in the November 2022, including complexity of activity, number of social places visited, and restaurants visited.

    R4.2.2 was used for exploratory factor analysis (EFA), Propensity Score Matching (PSM), matched conditional logistic regression, and other statistical analyses. EFA was used to determine the analytical dimensions of the nucleic acid sampling factor[4], and the results are shown in Supplementary 2 (available in www.besjournal.com). PSM was used to mitigate the influence of age, gender, residential type, ventilation of residence, and compare “case” and “control” groups. Matched conditional logistic regression was used to determine independent risk factors associated with infection, expressedasoddsratios (OR) and 95% confidence intervals (95% CI). Descriptive statistics and $ {\chi }^{2} $/F test were used to analyze the differences of basic characteristics between cases and controls. Statistical significance was set at P < 0.05.

    Of the 995 participants, 217 were from the case group and 778 were from the control group. There were 522 males, accounting for 52.5% of the sample size, and of all participants, 159 were aged 60 years or above, accounting for 16.0% of the sample size. The difference between “case” and “control” groups before and after matching were not statistically significant (P > 0.05), as shown in Table 1.

    Table 1.  Basic characteristics of the study groups, n (%)

    VariablesBefore matchingAfter matching
    Case (N = 217)Control (N = 778)PCase (N = 217)Control (N = 217)P
    Gender
    Male121 (55.76)401 (51.54)0.271119 (54.84)121 (55.76)0.847
    Female96 (44.24)377 (48.46)98 (45.16)96 (44.24)
    Age (years)a
    18–2935 (16.13)154 (19.79)0.31739 (17.97)35 (16.13)0.405
    30–3954 (24.88)220 (28.28)67 (30.88)54 (24.88)
    40–4949 (22.58)156 (20.05)35 (16.13)49 (22.58)
    50–5946 (21.20)122 (15.68)40 (18.43)46 (21.20)
    60–6924 (11.06)94 (12.08)29 (13.36)24 (11.06)
    ≥ 709 (4.15)32 (4.11)7 (3.23)9 (4.15)
    Vaccination
    Yes195 (89.86)701 (90.10)0.769191 (88.02)195 (89.86)0.540
    No22 (10.14)77 (9.90)26 (11.98)22 (10.14)
    Chronic disease
    Yes46 (21.20)113 (14.52)0.01836 (16.59 )46 (21.20)0.220
    No171 (78.80)665 (85.48)181 (83.41)171 (78.80)
    Residential type
    Community203 (93.55)727 (93.46)0.754196 (90.32)203 (93.55)0.217
    Urban fringe area0 (0.00)2 (0.25)0 (0.00)0 (0.00)
    Cottage area14 (6.45)49 (6.29)21 (9.68)14 (6.45)
    Ventilation of residencea
    Not ventilated8 (3.69)23 (2.96)0.5697 (3.23)8 (3.69)0.657
    1–2 times a day190 (87.56)703 (90.36)195 (89.86)190 (87.56)
    Always ventilated19 (8.75)52 (6.68)15 (6.91)19 (8.76)
    Number of cohabitantsa
    033 (15.21)98 (12.60)0.47731 (14.29)33 (15.21)0.715
    1–2119 (54.84)438 (56.30)118 (54.38)119 (54.84)
    ≥ 365 (29.95)242 (31.10)68 (31.34)65 (29.95)
    Type of daily mask
    N9584 (38.71)397 (51.03)0.003107 (49.31)84 (38.71)0.044
    Disposable medical mask129 (59.45)375 (48.20)109 (50.23)129 (59.45)
    Disposable Face Mask4 (1.84)6 (0.77)1 (0.46)4 (1.84)
    Use of hand sanitizera
    Every time194 (89.41)733 (94.22)0.046210 (96.77)194 (89.40)0.002
    Occasional13 (5.99)28 (3.60)5 (2.30)13 (5.99)
    Hardly5 (2.30)5 (0.64)0 (0.00)5 (2.30)
    Never5 (2.30)12 (1.54)2 (0.92)5 (2.30)
    Complexity of activitya
    Simple activity history190 (87.56)713 (91.65)0.074201 (92.63)190 (87.56)0.101
    Complex24(11.06)51 (6.56)8 (3.69)24 (11.06)
    More complex3 (1.38)14 (1.80)8 (3.69)3 (1.38)
    Social places visiteda
    1112 (51.61)425 (54.63)0.169126 (58.06)112 (51.61)0.097
    274 (34.10)286 (36.76)72 (33.18)74 (34.10)
    319 (8.76)47 (6.04)12 (5.53)19 (8.76)
    412 (5.53)20 (2.57)7 (3.23)12 (5.53)
    Visit of restaurant
    Yes37 (17.05)70 (9.00)< 0.00121 (9.68)37 (17.05)< 0.001
    No180 (82.95)708 (91.00)196 (90.32)180 (82.95)
    Sampling frequencya
    Daily111 (51.16)249 (32.01)< 0.00169 (31.80)111 (51.15)< 0.001
    Once every 1–3 days102 (47.00)509 (65.41)147 (67.74)102 (47.00)
    Once every 4–5 days2 (0.92)2 (0.26)1 (0.46)2 (0.92)
    Rarely2 (0.92)15 (1.93)0 (0.00)2 (0.92)
    Hardly0 (0.00)3 (0.39)0 (0.00)0 (0.00)
      Note. aF test was used for analysis, and other variables were analyzed using the chi-square test.

    The results of the statistical analysis indicated that chronic diseases, daily wearing of non-N95 masks, infrequent use of hand sanitizers, restaurant visits, and a high frequency of nucleic acid sampling significantly increased the risk of SARS-CoV-2 infection, as shown in Table 1.

    The proportion of patients with chronic diseases (21.20%) was higher in the case group than that in the control group (14.52%). Compared with a chronic disease, a non-chronic disease reduced the infection rate of COVID-19 by 77% or 58% before and after matching, respectively, as shown in Table 1 and Figure 1. Liu's[5] meta-analysis showed that the prevalence of hypertension, diabetes, cardiovascular disease, and chronic lung disease among SARS-CoV-2 patients was 20.0%, 10.0%, 8.0%, and 3.0%, respectively. These findings are consistent with the results of this study on chronic diseases, suggesting that underlying chronic diseases increase the risk of SARS-CoV-2 infection. Approximately one-third of Chinese adults have hypertension, which increases the susceptibility of the Chinese population to SARS-CoV-2[6]. Therefore, it is necessary to strengthen early prevention measures for patients with chronic diseases, such asimmunization and disease monitoring.

    Figure 1.  Risk of SARS-CoV-2 infection with different influencing factors of before and after matching. The participants were coded as follows: 0 = control and 1 = case. The dots indicate the odds ratios (OR) and the horizontal lines indicate the lower and upper limits of the 95% confidence interval (95% CI).

    From a personal hygiene perspective, wearing masks and maintaining hand hygiene reduced the infection rate of COVID-19 in our study. Compared to non-N95, wearing N95 masks reduced the infection of COVID-19 by approximately 80%, as shown in Figure 1. The spatial grid structure of a mask provides a physical barrier that selectively retains particulate matter, effectively reducing the amount of viral exposure and the risk of infection for susceptible individuals. Jayaweera[7] demonstrated that wearing surgical masks can reduce droplet and aerosol leakage by 70%–80% when coughing, while wearing N95 or protective masks can reduce it by 95%, thus significantly reducing the risk of epidemic recurrence, which is consistent with the results of this study. Hand hygiene is crucial for preventing cross-infection, and proper hand washing can effectively remove microorganisms from the hand surface. Comparing occasional/hardly/never use of hand sanitizer, maintaining hand hygiene reduced the infection of COVID-19 by 83% or 205% before and after matching, as shown in Figure 1. Allison[8] showed that hand washing can reduce the risk of respiratory tract infection by 16% to 21%, which is also consistent with the findings of this study. This indicates that wearing masks and hand hygiene play essential roles in preventing infectious respiratory diseases during the COVID-19 epidemic.

    In our study, visiting restaurants improved the infection rate of COVID-19 by 98% and 106% before and after matching, respectively, as shown in Figure 1. Restaurants, which are closed environments where people gather and remain for long periods, can facilitate the transmission of SARS-CoV-2 through aerosols and droplets[9]. Thus, during the COVID-19 pandemic, the public should reduce their activities in poorly ventilated or confined spaces.

    Daily nucleic acid sampling increased the incidence of COVID-19 by 134% and 176% before and after matching, respectively, as shown in Figure 1. However, our study did not find any significant influence of the setting and arrangement of nucleic acid sampling sites and sampling practices on the infection risk, suggesting that the infection risk of COVID-19 might not come from nucleic acid sampling. With COVID-19 entering its peak during november 2022 in Beijing, the probability of healthy people encountering infected people during nucleic acid sampling was increased gradually[3]. The cases and controls selected in our study were from the same community, and the environment and number of positive cases were similar. Therefore, the number of surrounding infectious sources was similar during nucleic acid sampling, and an increase in the frequency of sampling may have increased the exposure risk at the sampling site or queuing period. These results suggested that gathering activities should be reduced during the COVID-19 pandemic.

    Based on the risk factors for COVID-19 infection in our study, it is suggested that during the epidemic period of other respiratory infectious diseases, a multi-faced prevention and control approach should be adopted. In susceptible populations, especially those with chronic diseases, disease monitoring and vaccination should be enforced in medical institutions, so as to prevent progression to serious disease. Personal protective measures such as mask wearing and hand hygiene should be promoted, and activities in confined spaces should be reduced. A combined approach will prevent worsening of the epidemic.

参考文献 (9)
补充材料:
23177+Supplementary Materials.pdf

目录

    /

    返回文章
    返回